Les Effets Indésirables des Vaccins

                     

                                  

En Bref
    L'OMS définit les effets indésirables comme tout événement médical défavorable qui suit la vaccination et qui n'a pas forcément une relation causale avec l'utilisation du vaccin. Les données des essais cliniques et des systèmes de surveillance apportent des informations concernant les effets indésirables des vaccins. Les vaccins engendrent des effets indésirables bénins transitoires : signes locaux (douleur, induration, érythème) et parfois des effets généraux (fièvre, irritabilité, fatigue, myalgie, céphalée, etc.). Pour certains vaccins, il existe des preuves scientifiques qu'ils sont associés à des effets indésirables sévères très rares. Cependant, les bénéfices de ces vaccins restent largement favorables en comparaison à la rareté de ces effets indésirables graves.

 

    Les effets indésirables qui diffèrent par rapport aux effets indésirables bénins communs à l'ensemble des vaccins sont : (chiffres de l'OMS)

Tableau résumé des effets secondaires en général

                                                       

cliquez

                          

Articles reliés : Méthodes de surveillance, Peur des composants des vaccins

                               Haut de page

Sources 

Revues systématiques

  • Grazina I, Mannocci A, Meggiolaro A, La Torre G. Is there an association between Stevens-Johnson Syndrome and vaccination? A systematic review. Ann Ig. févr 2020;32(1):81‑96. 5 (Prisma ●●●● Amstar ●●●)

  • Nic Lochlainn LM, de Gier B, van der Maas N, Strebel PM, Goodman T, van Binnendijk RS, et al. Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis. Lancet Infect Dis. nov 2019;19(11):1235‑45. (Prisma ●●●○ Amstar ●●○)

  • Villa A, Patton LL, Giuliano AR, Estrich CG, Pahlke SC, O’Brien KK, et al. Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines: Umbrella review of systematic reviews. The Journal of the American Dental Association. 1 avr 2020;151(4):245-254.e24. (Prisma ●●○○ Amstar ●○○)

  • Rosillon D, Willame C, Tavares Da Silva F, Guignard A, Caterina S, Welby S, et al. Meta-analysis of the risk of autoimmune thyroiditis, Guillain-Barré syndrome, and inflammatory bowel disease following vaccination with AS04-adjuvanted human papillomavirus 16/18 vaccine. Pharmacoepidemiol Drug Saf. sept 2020;29(9):1159‑67. (Prisma ●●●● Amstar ●●●)

  • Jørgensen L, Gøtzsche PC, Jefferson T. Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports. Syst Rev. 28 févr 2020;9:43. (Prisma ●●●○ Amstar ●●○)

  • Bergman H, Buckley BS, Villanueva G, Petkovic J, Garritty C, Lutje V, Riveros-Balta AX, Low N, Henschke N. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males. Cochrane Database Syst Rev. 2019 Nov 22;2019(11):CD013479. (Prisma ●●●● Amstar ●●●)

  • Jiang HY, Shi YD, Zhang X, Pan LY, Xie YR, Jiang CM, et al. Human papillomavirus vaccination and the risk of autoimmune disorders: A systematic review and meta-analysis. Vaccine. 21 mai 2019;37(23):3031‑9. (Prisma ●●○○ Amstar ●○○)

  • Lu QC, Zhang TY, Bundhun PK, Chen C. One « misunderstood » health issue: demonstrating and communicating the safety of influenza a vaccination in pregnancy: a systematic review and meta-analysis. BMC Public Health. 9 avr 2021;21(1):703.  (Prisma ●●●● Amstar ●●●)

  • Zhang L, Prietsch SOM, Axelsson I, Halperin SA. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev. 17 sept 2014;(9):CD001478.

  • Jefferson T, Rudin M, Di Pietrantonj C. Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence. Lancet Infect Dis. févr 2004;4(2):84‑90.

  • Vichnin M, Bonanni P, Klein NP, Garland SM, Block SL, Kjaer SK, et al. An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015. Pediatr Infect Dis J. sept 2015;34(9):983‑91.

  • Swingler G, Fransman D, Hussey G. Conjugate vaccines for preventing Haemophilus influenzae type B infections. Cochrane Database Syst Rev. 18 avr 2007;(2):CD001729.

  • Lu B, Kumar A, Castellsagué X, Giuliano AR. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis. 12 janv 2011;11:13.

  • Obonyo CO, Lau J. Efficacy of Haemophilus influenzae type b vaccination of children: a meta-analysis. Eur J Clin Microbiol Infect Dis. févr 2006;25(2):90‑7.

  • Snape MD, Pollard AJ. Meningococcal polysaccharide-protein conjugate vaccines. Lancet Infect Dis. janv 2005;5(1):21‑30.

  • Angelo M-G, Zima J, Tavares Da Silva F, Baril L, Arellano F. Post-licensure safety surveillance for human papillomavirus-16/18-AS04-adjuvanted vaccine: more than 4 years of experience. Pharmacoepidemiol Drug Saf. mai 2014;23(5):456‑65.

  • Pomfret TC, Gagnon JM, Gilchrist AT. Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics. J Clin Pharm Ther. févr 2011;36(1):1‑9.

  • Ruiz-Aragón J, Márquez Peláez S, Molina-Linde JM, Grande-Tejada AM. Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in infants: a meta-analysis. Vaccine. 4 nov 2013;31(46):5349‑58.

  • Stillo M, Carrillo Santisteve P, Lopalco PL. Safety of human papillomavirus vaccines: a review. Expert Opin Drug Saf. mai 2015;14(5):697‑712.

  • Maglione MA, Gidengil C, Das L, Raaen L, Smith A, Chari R, et al. Safety of Vaccines Used for Routine Immunization in the United States. Agency for Healthcare Research and Quality (US); 2014.

  • Maglione MA, Das L, Raaen L, Smith A, Chari R, Newberry S, et al. Safety of vaccines used for routine immunization of U.S. children: a systematic review. Pediatrics. août 2014;134(2):325‑37.

  • Gonçalves AK, Cobucci RN, Rodrigues HM, de Melo AG, Giraldo PC. Safety, tolerability and side effects of human papillomavirus vaccines: a systematic quantitative review. Braz J Infect Dis. déc 2014;18(6):651‑9.

  • Jefferson T, Rudin M, DiPietrantonj C. Systematic review of the effects of pertussis vaccines in children. Vaccine. 16 mai 2003;21(17‑18):2003‑14.

  • Halsey NA, Talaat KR, Greenbaum A, Mensah E, Dudley MZ, Proveaux T, et al. The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper. Vaccine. 30 déc 2015;33 Suppl 5:F1‑67.

  • Chen N, Li Q, Zhang Y, Zhou M, Zhou D, He L. Vaccination for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 16 mars 2011;(3):CD007795.

  • Ferahta N, Achek I, Dubourg J, Lang P-O. [Vaccines against Herpes zoster: Effectiveness, safety, and cost/benefit ratio]. Presse Med. févr 2016;45(2):162‑76.

  • Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev. 15 févr 2012;(2):CD004407.

  • Gagliardi AMZ, Andriolo BNG, Torloni MR, Soares BGO. Vaccines for preventing herpes zoster in older adults. Cochrane Database Syst Rev. 3 mars 2016;3:CD008858.

  • Demicheli V, Jefferson T, Ferroni E, Rivetti A, Di Pietrantonj C. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 01 2018;2:CD001269.

  • Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 01 2018;2:CD004879.

  • Demicheli V, Jefferson T, Di Pietrantonj C, Ferroni E, Thorning S, Thomas RE, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 01 2018;2:CD004876.

  • Tricco AC, Zarin W, Cardoso R, Veroniki A-A, Khan PA, Nincic V, et al. Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis. BMJ. 25 oct 2018;363:k4029.  

Littérature grise

 

Affichages : 8791